The U.S. Food and Drug Administration (FDA) has accepted a new drug application from Jazz Pharmaceuticals for a capsule ...

Medical cannabis may offer little meaningful benefit for people with insomnia, according to a new review published in the ...

CBD gummies or CBD oil? How the two compare on portioning, taste and ingredients, and how to stay within the FSA's 10mg daily ...

Among people with premenstrual symptoms who used cannabis, the amount of dried flower they consumed tended to climb in the ...

Management attributes the raised 2026 revenue guidance to outstanding field execution and a slower-than-anticipated impact ...

A preclinical study reports that cannabidiol selectively impaired viability, migration, invasion, and clonogenic survival of ...

Canna River's CBD + CBN Sleep Gummies contain 50mg of each cannabinoid per gummy. The review examines their formulations, THC content, evidence, pricing, and safety considerations.

A full-spectrum cannabidiol (CBD)-rich extract reduced ultraviolet-induced skin tumor incidence by 75% in mice, while cutting ...

Jazz Pharmaceuticals JAZZ reported a third-quarter 2026 adjusted loss of $3.88 per share, narrower than the Zacks Consensus ...

<?xml encoding="utf-8" ?> Jazz Pharmaceuticals JAZZ reported third-quarter financial results on Monday. The transcript from ...

A discussion of workplace drug and alcohol use, abuse, and testing, focusing on private employers’ compliance with state and ...